130 related articles for article (PubMed ID: 3029708)
1. Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence.
Choo KH; Raphael K; McAdam W; Peterson MG
Nucleic Acids Res; 1987 Feb; 15(3):871-84. PubMed ID: 3029708
[TBL] [Abstract][Full Text] [Related]
2. Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells.
Anson DS; Austen DE; Brownlee GG
Nature; 1985 Jun 20-26; 315(6021):683-5. PubMed ID: 2989700
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human clotting factor IX cDNA expression in transgenic mice.
Hu Y; Qiu X; Xue J; Liu Z
Sci China B; 1995 Jul; 38(7):825-33. PubMed ID: 7626202
[TBL] [Abstract][Full Text] [Related]
4. Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.
Armentano D; Thompson AR; Darlington G; Woo SL
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6141-5. PubMed ID: 2385589
[TBL] [Abstract][Full Text] [Related]
5. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
6. Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques.
de la Salle H; Altenburger W; Elkaim R; Dott K; Dieterlé A; Drillien R; Cazenave JP; Tolstoshev P; Lecocq JP
Nature; 1985 Jul 18-24; 316(6025):268-70. PubMed ID: 4040611
[TBL] [Abstract][Full Text] [Related]
7. The gene structure of human anti-haemophilic factor IX.
Anson DS; Choo KH; Rees DJ; Giannelli F; Gould K; Huddleston JA; Brownlee GG
EMBO J; 1984 May; 3(5):1053-60. PubMed ID: 6329734
[TBL] [Abstract][Full Text] [Related]
8. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.
Wang L; Takabe K; Bidlingmaier SM; Ill CR; Verma IM
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3906-10. PubMed ID: 10097136
[TBL] [Abstract][Full Text] [Related]
9. Role of intron I in expression of the human factor IX gene.
Kurachi S; Hitomi Y; Furukawa M; Kurachi K
J Biol Chem; 1995 Mar; 270(10):5276-81. PubMed ID: 7890639
[TBL] [Abstract][Full Text] [Related]
10. The molecular pathology of haemophilia B. Fourth Wellcome Trust lecture.
Brownlee GG
Biochem Soc Trans; 1987 Feb; 15(1):1-8. PubMed ID: 3556729
[TBL] [Abstract][Full Text] [Related]
11. Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.
Yao SN; Wilson JM; Nabel EG; Kurachi S; Hachiya HL; Kurachi K
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8101-5. PubMed ID: 1896457
[TBL] [Abstract][Full Text] [Related]
12. Circulating human factor IX produced in keratin-promoter transgenic mice: a feasibility study for gene therapy of haemophilia B.
Alexander MY; Bidichandani SI; Cousins FM; Robinson CJ; Duffie E; Akhurst RJ
Hum Mol Genet; 1995 Jun; 4(6):993-9. PubMed ID: 7544665
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of the gene for human anti-haemophilic factor IX.
Choo KH; Gould KG; Rees DJ; Brownlee GG
Nature; 1982 Sep; 299(5879):178-80. PubMed ID: 6287289
[TBL] [Abstract][Full Text] [Related]
14. [High expression of human FIX(hFIX) in transgenic mice directed by goat beta-casein gene promoter].
Huang Z; Yan JB; Huang Y; Sun Q; Xiao YP; Huang Y; Zeng YT
Yi Chuan Xue Bao; 2002; 29(3):206-11. PubMed ID: 12182072
[TBL] [Abstract][Full Text] [Related]
15. Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.
Jallat S; Perraud F; Dalemans W; Balland A; Dieterle A; Faure T; Meulien P; Pavirani A
EMBO J; 1990 Oct; 9(10):3295-301. PubMed ID: 2209546
[TBL] [Abstract][Full Text] [Related]
16. Haemophilia B caused by a point mutation in a donor splice junction of the human factor IX gene.
Rees DJ; Rizza CR; Brownlee GG
Nature; 1985 Aug 15-21; 316(6029):643-5. PubMed ID: 4033760
[TBL] [Abstract][Full Text] [Related]
17. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.
Kay MA; Landen CN; Rothenberg SR; Taylor LA; Leland F; Wiehle S; Fang B; Bellinger D; Finegold M; Thompson AR
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2353-7. PubMed ID: 8134398
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of factor IX: defects in haemophilia B.
McGraw RA; Davis LM; Lundblad RL; Stafford DW; Roberts HR
Clin Haematol; 1985 Jun; 14(2):359-83. PubMed ID: 3899439
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
Smith TA; Mehaffey MG; Kayda DB; Saunders JM; Yei S; Trapnell BC; McClelland A; Kaleko M
Nat Genet; 1993 Dec; 5(4):397-402. PubMed ID: 8298650
[TBL] [Abstract][Full Text] [Related]
20. Expression of human factor IX and its subfragments in Escherichia coli and generation of antibodies to the subfragments.
Lin SW; Dunn JJ; Studier FW; Stafford DW
Biochemistry; 1987 Aug; 26(17):5267-74. PubMed ID: 2823876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
